Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy

被引:4
|
作者
Zhou, Yaofeng [1 ]
Li, Qianying [1 ]
Wu, Yuhao [1 ]
Zhang, Wan [2 ]
Ding, Lu [3 ]
Ji, Chenlin [4 ]
Li, Ping [1 ]
Chen, Tingtao [5 ]
Feng, Lili [6 ]
Tang, Ben Zhong [7 ]
Huang, Xiaolin [1 ]
机构
[1] Nanchang Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Resources, Nanchang 330047, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanchang 330006, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 1, Jiangxi Hypertens Res Inst, Dept Cardiol, Nanchang 330006, Peoples R China
[4] Westlake Univ, Sch Engn, Hangzhou 310030, Peoples R China
[5] Nanchang Univ, Natl Engn Res Ctr Bioengn Drugs & Technol, Inst Translat Med, Nanchang 330036, Peoples R China
[6] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Minist Educ, Harbin 150001, Peoples R China
[7] Chinese Univ Hong Kong Shenzhen CUHK Shenzhen, Sch Sci & Engn, Shenzhen 518172, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
engineered bacteria; multimodal cancer therapy; nanobiohybrid; nanomedicine; synergistic enhancement; PHOTOTHERMAL THERAPY; SYSTEMIC DELIVERY; RNA-INTERFERENCE; IMMUNE-RESPONSES; COATED BACTERIA; TUMOR; NANOPARTICLES; STRATEGY; SURFACE; CHEMOTHERAPY;
D O I
10.1002/adma.202313953
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Engineered bacteria are widely used in cancer treatment because live facultative/obligate anaerobes can selectively proliferate at tumor sites and reach hypoxic regions, thereby causing nutritional competition, enhancing immune responses, and producing anticancer microbial agents in situ to suppress tumor growth. Despite the unique advantages of bacteria-based cancer biotherapy, the insufficient treatment efficiency limits its application in the complete ablation of malignant tumors. The combination of nanomedicine and engineered bacteria has attracted increasing attention owing to their striking synergistic effects in cancer treatment. Engineered bacteria that function as natural vehicles can effectively deliver nanomedicines to tumor sites. Moreover, bacteria provide an opportunity to enhance nanomedicines by modulating the TME and producing substrates to support nanomedicine-mediated anticancer reactions. Nanomedicine exhibits excellent optical, magnetic, acoustic, and catalytic properties, and plays an important role in promoting bacteria-mediated biotherapies. The synergistic anticancer effects of engineered bacteria and nanomedicines in cancer therapy are comprehensively summarized in this review. Attention is paid not only to the fabrication of nanobiohybrid composites, but also to the interpromotion mechanism between engineered bacteria and nanomedicine in cancer therapy. Additionally, recent advances in engineered bacteria-synergized multimodal cancer therapies are highlighted. Herein, the first systematic and comprehensive review of the development of engineered bacteria in cancer, is provided; and the unique advantages of combining bacteria as anticancer agents with nanomedicines are discussed. This review focuses on the role of bacteria in cancer therapy, integration strategy of bacteria and nanotherapeutic drugs, synergistic mechanism of bacteria and nanomedicines, and bacteria-synergized multimodal cancer therapy. image
引用
收藏
页数:42
相关论文
共 50 条
  • [31] Polymeric nanomedicine for cancer therapy
    Park, Jae Hyung
    Lee, Seulki
    Kim, Jong-Ho
    Park, Kyeongsoon
    Kim, Kwangmeyung
    Kwon, Ick Chan
    PROGRESS IN POLYMER SCIENCE, 2008, 33 (01) : 113 - 137
  • [32] Nanomedicine in Bladder Cancer Therapy
    Winnicka, Adrianna
    Brzeszczynska, Joanna
    Saluk, Joanna
    Wigner-Jeziorska, Paulina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [33] Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine
    Susa, Francesca
    Limongi, Tania
    Dumontel, Bianca
    Vighetto, Veronica
    Cauda, Valentina
    CANCERS, 2019, 11 (12)
  • [34] Engineered microalgae for photo-sonodynamic synergistic therapy in breast cancer treatment
    Xu, Chaoli
    Dong, Jinhao
    Shi, Xuzhi
    Rui, Jiaxin
    Chen, Meng
    Lu, Wei
    Zhang, Aihua
    Wang, Shouju
    Teng, Zhaogang
    Ye, Xinhua
    ACTA BIOMATERIALIA, 2025, 193 : 531 - 544
  • [35] Amplifying Ca2+overload by engineered biomaterials for synergistic cancer therapy
    Liang, Jun-Long
    Cao, Yangyang
    Lv, Kaiwei
    Xiao, Bing
    Sun, Jihong
    BIOMATERIALS, 2025, 316
  • [36] Engineered bacteria to fight cancer
    不详
    BIOENGINEERED, 2016, 7 (06) : 394 - 394
  • [38] Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
    Tan, Junyi
    Duan, Xiaohui
    Zhang, Fang
    Ban, Xiaohua
    Mao, Jiaji
    Cao, Minghui
    Han, Shisong
    Shuai, Xintao
    Shen, Jun
    ADVANCED SCIENCE, 2020, 7 (24)
  • [39] Redox-responsive engineered hybrid nanomedicine for gallbladder cancer therapy via hyaluronic acid depletion
    Zou, Jinglin
    Jiang, Cong
    Li, Xianglong
    Zhong, Tianyu
    Wang, Shuqi
    Wang, Bo
    Zhang, Dapeng
    Hao, Ji-Na
    Cao, Yuanyuan
    Guan, Mengjia
    Zhang, Peng
    Dai, Bin
    Li, Yongsheng
    APPLIED MATERIALS TODAY, 2023, 30
  • [40] Progress of engineered bacteria for tumour therapy
    Xia, Xue
    Zhang, Jing-wen
    Zhao, Bing
    Zhang, Min
    Chen, Zhang-ren
    Zhang, Bing-feng
    Ji, Yu-long
    Wang, Xia
    Xiong, Wen-min
    Li, Jia-wei
    Lv, Qiao-li
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 132